UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between stomach cancer and oesophageal cancer clinical trials and research opportunities
~6,500 new UK cases annually. HER2-targeted therapies and immunotherapy combinations are driving trial activity, especially for advanced disease.
~9,000 new UK cases annually. The UK has one of the highest rates globally. Neoadjuvant chemotherapy and immunotherapy are key research areas.
Both upper GI cancers share some treatment approaches but have different risk factors and surgical considerations. Oesophageal has more curative-intent trial options.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
